4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexane,
PNU-3788A,
U 37883,
U 37883A,
U-37883,
U-37883A,
PNU 37883 hydrochloride,
57568-80-6,
U-37883A,
U 37883A,
PNU-37883A,
PNU 37883A,
U 37883,
U-37883,
4-Morpholinecarboximidine-N-1-adamantyl-N'-cyclohexane,
N-Cyclohexyl-N'-tricyclo(3.3.1.1(3,7))dec-1-yl-4-morpholinecarboximidamide monohydrochloride,
4-Morpholinecarboximidamide, N-cyclohexyl-N'-tricyclo(3.3.1.1(3,7))dec-1-yl-, monohydrochloride,
N-CYCLOHEXYL-N'-TRICYCLO[3.3.1.1(3,7)]DEC-1-YL-4-MORPHOLINECARBOXIMIDAMIDE HYDROCHLORIDE,
C21H35N3O.HCl,
AC1L213E,
CHEMBL541543,
SCHEMBL10619504,
SCHEMBL17978414,
CTK8G3684,
CTK8J4212,
DTXSID80206200,
AKOS024456944,
LP00096,
NCGC00015792-01,
NCGC00015792-02,
NCGC00092307-01,
NCGC00093598-01,
NCGC00162061-01,
LS-175856,
B6948,
EU-0100096,
SR-01000075196,
SR-01000075196-1,
N-(1-adamantyl)-N'-cyclohexylmorpholine-4-carboximidamide hydrochloride,
N-Adamantan-1-yl-N'-cyclohexyl-morpholine-4-carboxamidine hydrochloride,
N-Cyclohexyl-N'-tricyclo[3.3.1.13,7]dec-1-yl-4-morpholinecarboximidamide hydrochloride,
122252-09-9,
N-(1-Adamantyl)-N inverted exclamation marka-cyclohexyl-4-morpholinecarboxamidine hydrochloride,
C21H35N3O.ClH,
PNU-3788A,
FZALCKUJYZCDOX-UHFFFAOYSA-N,
C21-H35-N3-O.Cl-H,
CID64392,
C082658,